Haematological malignancies - Research Team

  • Professor Graham Anderson focuses on the role of the thymus in T-cell development, including approaches to improve immune reconstitution following ablative

    FIND OUT MORE

    Professor Graham  Anderson

  • Gavin Bendle is focussed on developing TCR gene transfer approaches to treat haematological malignancies, including in particular multiple myeloma.

    FIND OUT MORE

    Dr Gavin Bendle

  • David Briggs is a Consultant Clinical Scientist, and head of Histocompatibility and Immunogenetics at NHS Blood and Transplant, Birmingham. He

    FIND OUT MORE

    Professor David Briggs

  • Fred Chen is a consultant haematologist with a strong interest in Stem Cell Transplantation (SCT). Fred is closely involved in clinical

    FIND OUT MORE

    Dr Frederick Chen

  • Mark Cobbold is identifying and characterising the immune response to phosphopeptides, an emerging group of tumour-associated antigens. In addition, his work

    FIND OUT MORELinkedin

    Dr Mark Cobbold

  • Dr Mark Cook is a Consultant Haematologist at the Queen Elizabeth Hospital Birmingham (QEHB). Based in the Centre for Clinical Haematology,

    FIND OUT MORE

    Dr Mark Cook

  • Charlie Craddock is working with Dr Ram Malladi and Professor Paul Moss on clinical treatment of haematological malignancies, key approaches being

    FIND OUT MORE

    Professor Charlie Craddock

  • Dr Carmela De Santo is an expert on tumour immunosuppression, and in particular on myeloid derived suppressor cells.

    FIND OUT MORE

    Dr Carmela  De Santo

  • Mark Drayson leads the Birmingham Clinical Immunology Service (CIS), one of the largest diagnostic immunology services in the UK. The CIS

    FIND OUT MORE

    Professor Mark Drayson

  • Dr Sylvie Freeman is a Clinical Senior Lecturer and Honorary Consultant Haematologist in the departments of Clinical Immunology, University of Birmingham

    FIND OUT MORE

    Dr Sylvie Freeman

  • Dr Heather Long’s research is focused on developing immune T cell-based therapies for the treatment of EBV-associated and non-virus associated lymphomas.

    FIND OUT MORE

    Dr Heather Long

  • Ram Malladi is a consultant haematologist based at the Centre for Clinical Haematology, who works closely with Professor Charlie Craddock and

    FIND OUT MORE

    Dr Ram Malladi

  • Professor Moss’s research is focussed around the application of translational immunological research in the study of human cancer.

    FIND OUT MORE

    Professor Paul Moss

  • Dr Francis Mussai is a Clinical Senior Lecturer with a strong research interest in exploring the immunosuppressive microenvironment generated by paediatric

    FIND OUT MORE

    Dr Francis Mussai

  • Dr Guy Pratt is a consultant haematologist with a long-standing research interest in multiple myeloma and chronic lymphocytic leukaemia.

    FIND OUT MORE

    Dr Guy Pratt

  • Manoj Raghavan is a consultant haematologist based at the Centre for Clinical Haematology. Manoj works closely with Professor Charlie Craddock, and

    FIND OUT MORE

    Dr Manoj Raghavan